Andrew Whitten

Director, Product Marketing at Taiho Oncology, Inc.

Andrew Whitten has a diverse work experience spanning multiple industries. Andrew currently works at Taiho Oncology, Inc. as the Associate Director of Product Marketing. Prior to this, they held various roles within the company, including Associate Director of Market Access Marketing, Associate Director of Commercialization, Oncology Account Manager, and Oncology Account Specialist.

Before joining Taiho Oncology, Andrew worked at Oracle. Andrew served as the Applications Sales Manager for Oracle Business Analytics, where they provided reporting, analytics, and data warehousing solutions to clients in the Mid-Atlantic region. Andrew also worked as a Senior Applications Sales Representative, helping business leaders in the Southeast modernize their organizations using ERP, SCM, and EPM solutions. Additionally, they worked as a Business Development Consultant, specializing in Database Security and Identity Management.

Prior to their time at Oracle, Andrew worked as a Marketing Manager Intern at ScanSource, and as an Operations Assistant/Operations Manager at the Fike Recreation Center. Andrew also served as the Athletics Marketing Manager for the Clemson Athletic Department.

Andrew Whitten's experiences range from marketing and sales to operations and management, showcasing their versatility and expertise in various fields.

Andrew Whitten attended Clemson University from 2011 to 2015, where they obtained a Bachelor of Science (BS) degree in Marketing with a minor in Economics. In addition, they participated in a study abroad program at the Arcadia Center for Catalan, Spanish, and Mediterranean Studies in Barcelona, Spain.

Location

Philadelphia, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Taiho Oncology, Inc.

2 followers

The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com


Employees

201-500

Links